Study reveals new link between high temperature exposure and sphingolipid metabolism in obesity

FHS
May 29, 2024
6:49 pm

In contemporary society, obesity has emerged as a worldwide chronic metabolic disorder, imposing substantial burdens on both individual health and healthcare systems.

Artificial Intelligence Can Be an Effective Tool in Neurology

The American Academy of Neurology annual meeting featured several discussions on the impact of artificial intelligence (AI) on clinical practice in the field of neurology,

May 11, 2024

MSD closes $1.3bn EyeBio acquisition, plans pivotal trial for lead asset

MSD first announced the EyeBio acquisition in May. Credit: Michael Vi / Shutterstock. Two months after MSD (Merck & Co) set its eye on acquiring

July 12, 2024

Seelos’ stock plunges by over 75% after ketamine drug for suicide prevention fails a PhII trial

Seelos Therapeutics’ intranasal racemic ketamine candidate has missed the primary endpoint in a Phase II trial of major depressive disorder patients with acute suicidal ideation,

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.